Market Overview:
The global CRISPR gene editing tools market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for genetically modified crops, rising prevalence of chronic diseases, and growing application areas of CRISPR technology. Based on type, the global CRISPR gene editing tools market is segmented into Cas nuclease, guide RNA, DNA ligase, restriction endonuclease and others. The Cas nuclease segment is expected to hold the largest share in terms of revenue in 2018 owing to its high efficiency and specificity. Based on application, the global CRISPR gene editing tools market is segmented into agricultural biotechnology, biomedical research & therapeutics development (including human genetic disorders), industrial biotechnology (including biofuels production) and others (includes environmental biotechnology). The agricultural biotechnology sector accounted for the largest share in terms of revenue in 2017 owing to increasing adoption of genetically modified crops across the globe.
Product Definition:
CRISPR Gene Editing Tools are a set of tools used to edit genes. They are important because they allow scientists to modify genes in a way that could not be done before. This could lead to new treatments for diseases or other advances in science.
Cas Nuclease:
Cas nucleases are protein-based molecular machines that hydrolyze phosphates and DNA in the presence of an appropriate catalytic agent. The enzyme specificity is determined by four major domains: a zinc finger, a RNA recognition domain, an oligonucleotide specificity domain and a proteolytic activation domain.
The enzyme activity can be modulated by altering the conformation of individual domains or by binding to specific ligands.
Guide RNA:
Guide RNA (gRNA) is a type of molecule that acts as an input to the CRISPR/Cas9 system, which enables scientists and researchers in gene editing. It is also known as DNA guide or oligonucleotide guide. The gRNA can be either natural or synthetic in nature, but it should match the target sequence for successful gene silencing, transcriptional regulation or methylation.
The growing popularity of genome editing techniques has encouraged several research groups.
Application Insights:
The application segment is sub-divided into biomedical, agricultural and industrial applications. The biomedical application segment dominated the global market in terms of revenue in 2017. This can be attributed to its growing adoption for editing genomes for various purposes, such as disease treatment and genome research. In addition, increasing R&D investments by companies and academic institutions are further driving the growth of this segment over the forecast period.
Agricultural applications are expected to witness significant growth over the forecast period owing to its rising adoption across diverse fields such as crop improvement, breeding programs and livestock genetic modification & enhancement. Moreover, CRISPR/Cas9 has numerous potential uses in agriculture that include improving plant health by enhancing resistance against pests & diseases or enabling tolerance towards abiotic stresses like cold temperatures or drought conditions (Kumar et al., 2016).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of CRISPR patent holders and academic and research institutes that are engaged in R&D activities. The region is expected to maintain its dominance over the forecast period due to ongoing collaborative efforts by major companies with well-established universities/academia. For instance, Novogene Corporation entered into a collaboration with Uppsala University for commercialization of CGT technologies.
Asia Pacific is anticipated to grow at an exponential rate during the forecast period owing to increasing investments by governments as well as private entities in this region for agricultural development coupled with biomedical research applications pertaining genetic modification techniques including CRISPR technology. Moreover, growing awareness among people regarding emerging technologies such as genome editing has led them towards adoption of these systems which will further boost growth over next eight years time frame.
China has been observed making significant progressions through various initiatives taken up by government agencies such as National Development.
Growth Factors:
- Increasing demand for CRISPR gene editing tools in the biotechnology and pharmaceutical industries for research and development purposes.
- Rising number of CRISPR patent filings and commercial licenses by key players in the market.
- Growing investments by venture capitalists in startups involved in CRISPR gene editing tools technology development.
- Proliferation of next-generation sequencing (NGS) platforms that are compatible with CRISPR gene editing tools, which is aiding their wider adoption across research institutes and laboratories.
Scope Of The Report
Report Attributes
Report Details
Report Title
CRISPR Gene Editing Tools Market Research Report
By Type
Cas Nuclease, Guide RNA, DNA ligase, Restriction Endonuclease, Others
By Application
Agricultural, Biomedical, Industrial, Others
By Companies
Abcam, Inc., Agilent Technologies, Inc., CRISPR Therapeutics AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Integrated DNA Technologies, Inc., New England Biolabs, Inc., Origene Technologies, Inc., Rockland Immunochemicals, Inc., Thermo Fisher Scientific, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global CRISPR Gene Editing Tools Market Report Segments:
The global CRISPR Gene Editing Tools market is segmented on the basis of:
Types
Cas Nuclease, Guide RNA, DNA ligase, Restriction Endonuclease, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Agricultural, Biomedical, Industrial, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam, Inc.
- Agilent Technologies, Inc.
- CRISPR Therapeutics AG
- GeneCopoeia, Inc.
- GenScript Biotech Corporation
- Integrated DNA Technologies, Inc.
- New England Biolabs, Inc.
- Origene Technologies, Inc.
- Rockland Immunochemicals, Inc.
- Thermo Fisher Scientific, Inc.
Highlights of The CRISPR Gene Editing Tools Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cas Nuclease
- Guide RNA
- DNA ligase
- Restriction Endonuclease
- Others
- By Application:
- Agricultural
- Biomedical
- Industrial
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the CRISPR Gene Editing Tools Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
CRISPR gene editing tools are a new way to edit genes. They work by cutting the DNA of a gene and then replacing it with another piece of DNA. This can be done using either traditional methods or CRISPR technology.
Some of the major companies in the crispr gene editing tools market are Abcam, Inc., Agilent Technologies, Inc., CRISPR Therapeutics AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Integrated DNA Technologies, Inc., New England Biolabs, Inc., Origene Technologies, Inc., Rockland Immunochemicals, Inc., Thermo Fisher Scientific, Inc..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 CRISPR Gene Editing Tools Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 CRISPR Gene Editing Tools Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 CRISPR Gene Editing Tools Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the CRISPR Gene Editing Tools Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global CRISPR Gene Editing Tools Market Size & Forecast, 2018-2028
4.5.1 CRISPR Gene Editing Tools Market Size and Y-o-Y Growth
4.5.2 CRISPR Gene Editing Tools Market Absolute $ Opportunity
Chapter 5 Global CRISPR Gene Editing Tools Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 CRISPR Gene Editing Tools Market Size Forecast by Type
5.2.1 Cas Nuclease
5.2.2 Guide RNA
5.2.3 DNA ligase
5.2.4 Restriction Endonuclease
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global CRISPR Gene Editing Tools Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 CRISPR Gene Editing Tools Market Size Forecast by Applications
6.2.1 Agricultural
6.2.2 Biomedical
6.2.3 Industrial
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global CRISPR Gene Editing Tools Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 CRISPR Gene Editing Tools Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America CRISPR Gene Editing Tools Analysis and Forecast
9.1 Introduction
9.2 North America CRISPR Gene Editing Tools Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America CRISPR Gene Editing Tools Market Size Forecast by Type
9.6.1 Cas Nuclease
9.6.2 Guide RNA
9.6.3 DNA ligase
9.6.4 Restriction Endonuclease
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America CRISPR Gene Editing Tools Market Size Forecast by Applications
9.10.1 Agricultural
9.10.2 Biomedical
9.10.3 Industrial
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe CRISPR Gene Editing Tools Analysis and Forecast
10.1 Introduction
10.2 Europe CRISPR Gene Editing Tools Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe CRISPR Gene Editing Tools Market Size Forecast by Type
10.6.1 Cas Nuclease
10.6.2 Guide RNA
10.6.3 DNA ligase
10.6.4 Restriction Endonuclease
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe CRISPR Gene Editing Tools Market Size Forecast by Applications
10.10.1 Agricultural
10.10.2 Biomedical
10.10.3 Industrial
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific CRISPR Gene Editing Tools Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific CRISPR Gene Editing Tools Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific CRISPR Gene Editing Tools Market Size Forecast by Type
11.6.1 Cas Nuclease
11.6.2 Guide RNA
11.6.3 DNA ligase
11.6.4 Restriction Endonuclease
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific CRISPR Gene Editing Tools Market Size Forecast by Applications
11.10.1 Agricultural
11.10.2 Biomedical
11.10.3 Industrial
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America CRISPR Gene Editing Tools Analysis and Forecast
12.1 Introduction
12.2 Latin America CRISPR Gene Editing Tools Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America CRISPR Gene Editing Tools Market Size Forecast by Type
12.6.1 Cas Nuclease
12.6.2 Guide RNA
12.6.3 DNA ligase
12.6.4 Restriction Endonuclease
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America CRISPR Gene Editing Tools Market Size Forecast by Applications
12.10.1 Agricultural
12.10.2 Biomedical
12.10.3 Industrial
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) CRISPR Gene Editing Tools Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) CRISPR Gene Editing Tools Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) CRISPR Gene Editing Tools Market Size Forecast by Type
13.6.1 Cas Nuclease
13.6.2 Guide RNA
13.6.3 DNA ligase
13.6.4 Restriction Endonuclease
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) CRISPR Gene Editing Tools Market Size Forecast by Applications
13.10.1 Agricultural
13.10.2 Biomedical
13.10.3 Industrial
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 CRISPR Gene Editing Tools Market: Competitive Dashboard
14.2 Global CRISPR Gene Editing Tools Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam, Inc.
14.3.2 Agilent Technologies, Inc.
14.3.3 CRISPR Therapeutics AG
14.3.4 GeneCopoeia, Inc.
14.3.5 GenScript Biotech Corporation
14.3.6 Integrated DNA Technologies, Inc.
14.3.7 New England Biolabs, Inc.
14.3.8 Origene Technologies, Inc.
14.3.9 Rockland Immunochemicals, Inc.
14.3.10 Thermo Fisher Scientific, Inc.
